home

 

Providing Targeted Cancer Diagnostics

News

Advanced Diagnostics Adopts Roche Companion Diagnostics Testing Platform

Advanced Diagnostics has chosen to adopt Roche Pathway HER2 (4B5) on the Benchmark ULTRA automated staining system for use in breast and gastric cancer HER2 testing applications.